338220 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
VUNO, Inc. engages in the development of development of artificial intelligence based medical solutions. It offers diagnostic support decision tools and systems such as bone age assessment tool, chest x-ray, pulmonary lung nodule detection and reporting system, eye fundus screening solution, neuro degenerative disease quantification tool, and cardiac activity warning system. The company was founded by Ye-Ha Lee, Hyun-Jun Kim, and Kyu-Hwan Jung on December 10, 2014 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
338220 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company